Home Healthcare IT Asia Pacific Cell and Gene Therapy Manufacturing QC Market Size, Share & Trends | Industry

Asia Pacific Cell and Gene Therapy Manufacturing QC Market Size, Share & Trends Analysis Report By Therapy Type (Cell Therapy, CAR-T, CAR-NK, B-Cell, Others, Gene Therapy, Viral, Non-viral), By Scale (Pre-commercial/ R&D Manufacturing, Commercial Scale Manufacturing), By Mode (Contract Manufacturing, In-house Manufacturing), By Workflow (Cell Processing, Cell Banking, Fill & Finish Operations, Raw Material Testing, Vector Production, Other Workflows), By Process (Upstream Processes, Downstream Processes), By End-User (Pharmaceutical Companies, Biopharmaceutical / Biotechnological Companies, Contract Manufacturing Organizations), By Technology Type (Fluorescence-Activated Cell Sorting (FACS), Enzyme-Linked Immunosorbent Assay (ELISA), Chromatography, Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Others) and By Country (China, Korea, Japan, India, Australia, Taiwan, South East Asia, Rest of Asia-Pacific) Forecasts, 2025-2033

Report Code: SRHI56472DR
Last Updated: Jul, 2025
Pages: 80
Author: Debashree Bora
Format: PDF, Excel

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  2. ESG Trends
  3. ESG Trends
    1. Introduction
    2. By Therapy Type
      1. Introduction
        1. Therapy Type By Value
      2. Cell Therapy
        1. By Value
        2. CAR-T
          1. CAR-T By Value
          2. Autologous CAR-T
            1. Autologous CAR-T By Value
          3. Allogeneic CAR-T
            1. Allogeneic CAR-T By Value
        3. CAR-NK
          1. CAR-NK By Value
        4. B-Cell
          1. B-Cell By Value
        5. Others
          1. Others By Value
      3. Gene Therapy
        1. By Value
        2. Viral
          1. Viral By Value
          2. AAV
            1. AAV By Value
          3. Lentiviral vectors
            1. Lentiviral vectors By Value
          4. Other
            1. Other By Value
        3. Non-Viral
          1. Non-Viral By Value
    3. By Scale
      1. Introduction
        1. Scale By Value
      2. Pre-commercial/ R&D Manufacturing
        1. By Value
      3. Commercial Scale Manufacturing
        1. By Value
    4. By Mode
      1. Introduction
        1. Mode By Value
      2. Contract Manufacturing
        1. By Value
      3. In-house Manufacturing
        1. By Value
    5. By Workflow
      1. Introduction
        1. Workflow By Value
      2. Cell Processing
        1. By Value
      3. Cell Banking
        1. By Value
      4. Fill & Finish Operations
        1. By Value
      5. Raw Material Testing
        1. By Value
      6. Vector Production
        1. By Value
      7. Other Workflows
        1. By Value
    6. By Process
      1. Introduction
        1. Process By Value
      2. Upstream Processes
        1. By Value
      3. Downstream Processes
        1. By Value
    7. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical Companies
        1. By Value
        2. Small Size
          1. Small Size By Value
        3. Medium Size
          1. Medium Size By Value
        4. Large Size
          1. Large Size By Value
      3. Biopharmaceutical / Biotechnological Companies
        1. By Value
        2. Small Size
          1. Small Size By Value
        3. Medium Size
          1. Medium Size By Value
        4. Large Size
          1. Large Size By Value
      4. Contract Manufacturing Organizations
        1. By Value
        2. Small Size
          1. Small Size By Value
        3. Medium Size
          1. Medium Size By Value
        4. Large Size
          1. Large Size By Value
    8. By Technology Type
      1. Introduction
        1. Technology Type By Value
      2. Fluorescence-Activated Cell Sorting (FACS)
        1. By Value
      3. Enzyme-Linked Immunosorbent Assay (ELISA)
        1. By Value
      4. Chromatography
        1. By Value
      5. Next-Generation Sequencing (NGS)
        1. By Value
      6. Polymerase Chain Reaction (PCR)
        1. By Value
      7. Others
        1. By Value
    9. China
      1. By Therapy Type
        1. Introduction
          1. Therapy Type By Value
        2. Cell Therapy
          1. By Value
          2. CAR-T
            1. CAR-T By Value
            2. Autologous CAR-T
              1. Autologous CAR-T By Value
            3. Allogeneic CAR-T
              1. Allogeneic CAR-T By Value
          3. CAR-NK
            1. CAR-NK By Value
          4. B-Cell
            1. B-Cell By Value
          5. Others
            1. Others By Value
        3. Gene Therapy
          1. By Value
          2. Viral
            1. Viral By Value
            2. AAV
              1. AAV By Value
            3. Lentiviral vectors
              1. Lentiviral vectors By Value
            4. Other
              1. Other By Value
          3. Non-Viral
            1. Non-Viral By Value
      2. By Scale
        1. Introduction
          1. Scale By Value
        2. Pre-commercial/ R&D Manufacturing
          1. By Value
        3. Commercial Scale Manufacturing
          1. By Value
      3. By Mode
        1. Introduction
          1. Mode By Value
        2. Contract Manufacturing
          1. By Value
        3. In-house Manufacturing
          1. By Value
      4. By Workflow
        1. Introduction
          1. Workflow By Value
        2. Cell Processing
          1. By Value
        3. Cell Banking
          1. By Value
        4. Fill & Finish Operations
          1. By Value
        5. Raw Material Testing
          1. By Value
        6. Vector Production
          1. By Value
        7. Other Workflows
          1. By Value
      5. By Process
        1. Introduction
          1. Process By Value
        2. Upstream Processes
          1. By Value
        3. Downstream Processes
          1. By Value
      6. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharmaceutical Companies
          1. By Value
          2. Small Size
            1. Small Size By Value
          3. Medium Size
            1. Medium Size By Value
          4. Large Size
            1. Large Size By Value
        3. Biopharmaceutical / Biotechnological Companies
          1. By Value
          2. Small Size
            1. Small Size By Value
          3. Medium Size
            1. Medium Size By Value
          4. Large Size
            1. Large Size By Value
        4. Contract Manufacturing Organizations
          1. By Value
          2. Small Size
            1. Small Size By Value
          3. Medium Size
            1. Medium Size By Value
          4. Large Size
            1. Large Size By Value
      7. By Technology Type
        1. Introduction
          1. Technology Type By Value
        2. Fluorescence-Activated Cell Sorting (FACS)
          1. By Value
        3. Enzyme-Linked Immunosorbent Assay (ELISA)
          1. By Value
        4. Chromatography
          1. By Value
        5. Next-Generation Sequencing (NGS)
          1. By Value
        6. Polymerase Chain Reaction (PCR)
          1. By Value
        7. Others
          1. By Value
    10. Korea
    11. Japan
    12. India
    13. Australia
    14. Taiwan
    15. South East Asia
    16. Rest of Asia-Pacific
    1. Asia Pacific Cell and Gene Therapy Manufacturing QC Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Lonza
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Pharmaron
    3. Merck KGaA
    4. Catalent Inc.
    5. Charles River Laboratories
    6. Thermo Fisher Scientific Inc.
    7. WuXi AppTec
    8. Alcami Corporation
    9. IQVIA Inc.
    10. SGS Société Générale de Surveillance SA
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  4. Disclaimer
Get This Report

Download Free Sample

We are featured on:

WhatsApp
Chat with us on WhatsApp
Address:
Office 515 A, Amanora Chambers,
Amanora Park Town, Hadapsar,
Pune 411028, Maharashtra, India.
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
DMCA.com Protection Status
Secure Payments:
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.